TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment of Sleep-Disordered Breathing With Predominant Central Sleep Apnea by Adaptive Servo Ventilation in Patients With Heart Failure
Brief Summary: The purpose of this trial is to evaluate the long-term effects and cost-effectiveness of adaptive servo-ventilation (ASV) on the mortality and morbidity of patients with stable heart failure due to left ventricular systolic dysfunction, already receiving optimal medical therapy, who have sleep disordered breathing (SDB) that is predominantly central sleep apnea. Assumptions: the intervention reduces the hazard rate by 20%. The event rate in the control group is 35% in the first year. It is assumed that the hazard rate is constant over time.


Options:
A: Arm Label: positive airway pressure; Type: EXPERIMENTAL; Interventions: Device: CPAP | Intervention Type: DEVICE; Name: CPAP; Assigned to Arm(s): positive airway pressure
B: Arm Label: Nocturnal oxygen therapy; Type: ACTIVE_COMPARATOR; Interventions: Device: Nocturnal oxygen | Arm Label: Adaptive servo ventilation; Type: ACTIVE_COMPARATOR; Interventions: Device: Adaptive servo ventilation | Intervention Type: DEVICE; Name: Adaptive servo ventilation; Assigned to Arm(s): Adaptive servo ventilation | Intervention Type: DEVICE; Name: Nocturnal oxygen; Assigned to Arm(s): Nocturnal oxygen therapy
C: Arm Label: MV ASV+OMT; Type: EXPERIMENTAL; Interventions: Device: MV ASV, Drug: Optimized Medical Treatment | Arm Label: OMT only; Type: ACTIVE_COMPARATOR; Interventions: Drug: Optimized Medical Treatment | Intervention Type: DEVICE; Name: MV ASV; Assigned to Arm(s): MV ASV+OMT | Intervention Type: DRUG; Name: Optimized Medical Treatment; Assigned to Arm(s): MV ASV+OMT, OMT only
D: Arm Label: Treatment Group; Type: ACTIVE_COMPARATOR; Interventions: Device: Europe: AutoSet CS (USA: VPAP Adapt SV) | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Europe: AutoSet CS (USA: VPAP Adapt SV); Assigned to Arm(s): Treatment Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment of Sleep-Disordered Breathing With Predominant Central Sleep Apnea by Adaptive Servo Ventilation in Patients With Heart Failure
Brief Summary: The purpose of this trial is to evaluate the long-term effects and cost-effectiveness of adaptive servo-ventilation (ASV) on the mortality and morbidity of patients with stable heart failure due to left ventricular systolic dysfunction, already receiving optimal medical therapy, who have sleep disordered breathing (SDB) that is predominantly central sleep apnea. Assumptions: the intervention reduces the hazard rate by 20%. The event rate in the control group is 35% in the first year. It is assumed that the hazard rate is constant over time.


Options:
A: Arm Label: Treatment Group; Type: EXPERIMENTAL; Interventions: Device: Treatment Group (transvenous stimulation of the phrenic nerve) | Arm Label: Control group; Type: OTHER; Interventions: Device: Control Group (Optimal Medical Therapy) | Intervention Type: DEVICE; Name: Treatment Group (transvenous stimulation of the phrenic nerve); Assigned to Arm(s): Treatment Group | Intervention Type: DEVICE; Name: Control Group (Optimal Medical Therapy); Assigned to Arm(s): Control group
B: Arm Label: SACUBITRIL - VALSARTAN; Type: EXPERIMENTAL; Interventions: Drug: SACUBITRIL - VALSARTAN (formerly LCZ696, ENTRESTO®) | Intervention Type: DRUG; Name: SACUBITRIL - VALSARTAN (formerly LCZ696, ENTRESTO®); Assigned to Arm(s): SACUBITRIL - VALSARTAN
C: Arm Label: acetazolamide; Type: EXPERIMENTAL; Interventions: Drug: acetazolamide | Arm Label: Placebo tablet; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo tablet | Arm Label: supplemental oxygen during nights; Type: EXPERIMENTAL; Interventions: Other: Supplemental oxygen | Arm Label: Non-invasive ventilation; Type: EXPERIMENTAL; Interventions: Procedure: Non-invasive ventilation | Arm Label: room air; Type: SHAM_COMPARATOR; Interventions: Other: Room air | Intervention Type: DRUG; Name: acetazolamide; Assigned to Arm(s): acetazolamide | Intervention Type: OTHER; Name: Supplemental oxygen; Assigned to Arm(s): supplemental oxygen during nights | Intervention Type: PROCEDURE; Name: Non-invasive ventilation; Assigned to Arm(s): Non-invasive ventilation | Intervention Type: OTHER; Name: Room air; Assigned to Arm(s): room air | Intervention Type: DRUG; Name: Placebo tablet; Assigned to Arm(s): Placebo tablet
D: Arm Label: Treatment Group; Type: ACTIVE_COMPARATOR; Interventions: Device: Europe: AutoSet CS (USA: VPAP Adapt SV) | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Europe: AutoSet CS (USA: VPAP Adapt SV); Assigned to Arm(s): Treatment Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Adherence With Oral Contraceptives Using Daily Text Messaging Reminders
Brief Summary: The purpose of this study is to determine whether there is increased oral contraceptive pill (OCP) adherence in women receiving daily text messaging reminders to take their OCP, compared to women who do not receive reminders. The investigators hypothesize that women who receive daily text messaging reminders to take their OCP will have increased pill adherence compared to women who do not receive reminders.

The investigators also hope to determine whether there is a difference in OCP adherence as measured by electronic monitoring device and wireless real-time data collection versus traditional patient pill diaries. The investigators hypothesize that electronic monitoring device and wireless real-time data collection will demonstrate lower adherence compared to traditional patient pill diaries.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Contraceptive text messages | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Text messages not about contraception | Intervention Type: BEHAVIORAL; Name: Contraceptive text messages; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Text messages not about contraception; Assigned to Arm(s): Control
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Text messaging reminders | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Text messaging reminders; Assigned to Arm(s): 1
C: Arm Label: Text Messaging Intervention; Type: EXPERIMENTAL; Interventions: Other: Text Messaging Intervention | Arm Label: Standard Referral; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard Referral | Intervention Type: OTHER; Name: Text Messaging Intervention; Assigned to Arm(s): Text Messaging Intervention | Intervention Type: OTHER; Name: Standard Referral; Assigned to Arm(s): Standard Referral
D: Arm Label: Standard Treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-help materials, Drug: nicotine patch, Behavioral: Counseling | Arm Label: Automated Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Self-help materials, Drug: nicotine patch, Other: Smartphone-delivered automated treatment | Intervention Type: BEHAVIORAL; Name: Self-help materials; Assigned to Arm(s): Automated Treatment, Standard Treatment | Intervention Type: DRUG; Name: nicotine patch; Assigned to Arm(s): Automated Treatment, Standard Treatment | Intervention Type: BEHAVIORAL; Name: Counseling; Assigned to Arm(s): Standard Treatment | Intervention Type: OTHER; Name: Smartphone-delivered automated treatment; Assigned to Arm(s): Automated Treatment

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Adherence With Oral Contraceptives Using Daily Text Messaging Reminders
Brief Summary: The purpose of this study is to determine whether there is increased oral contraceptive pill (OCP) adherence in women receiving daily text messaging reminders to take their OCP, compared to women who do not receive reminders. The investigators hypothesize that women who receive daily text messaging reminders to take their OCP will have increased pill adherence compared to women who do not receive reminders.

The investigators also hope to determine whether there is a difference in OCP adherence as measured by electronic monitoring device and wireless real-time data collection versus traditional patient pill diaries. The investigators hypothesize that electronic monitoring device and wireless real-time data collection will demonstrate lower adherence compared to traditional patient pill diaries.


Options:
A: Arm Label: Reminder module (SMS and Phone call); Type: EXPERIMENTAL; Interventions: Behavioral: Reminder module (SMS and Phone call) | Arm Label: Photovoice; Type: EXPERIMENTAL; Interventions: Behavioral: Photovoice | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Reminder module (SMS and Phone call); Assigned to Arm(s): Reminder module (SMS and Phone call) | Intervention Type: BEHAVIORAL; Name: Photovoice; Assigned to Arm(s): Photovoice
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Text messaging reminders | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Text messaging reminders; Assigned to Arm(s): 1
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Contraceptive text messages | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Text messages not about contraception | Intervention Type: BEHAVIORAL; Name: Contraceptive text messages; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Text messages not about contraception; Assigned to Arm(s): Control
D: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Reminders; Type: EXPERIMENTAL; Interventions: Behavioral: Reminders | Intervention Type: BEHAVIORAL; Name: Reminders; Assigned to Arm(s): Reminders

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Adherence With Oral Contraceptives Using Daily Text Messaging Reminders
Brief Summary: The purpose of this study is to determine whether there is increased oral contraceptive pill (OCP) adherence in women receiving daily text messaging reminders to take their OCP, compared to women who do not receive reminders. The investigators hypothesize that women who receive daily text messaging reminders to take their OCP will have increased pill adherence compared to women who do not receive reminders.

The investigators also hope to determine whether there is a difference in OCP adherence as measured by electronic monitoring device and wireless real-time data collection versus traditional patient pill diaries. The investigators hypothesize that electronic monitoring device and wireless real-time data collection will demonstrate lower adherence compared to traditional patient pill diaries.


Options:
A: Arm Label: 1 Standard Care (SC); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2 Standard Care + Educational (SCE); Type: OTHER; Interventions: Behavioral: educational instruction in clinic | Arm Label: 3 Standard Care + Educational + Phone Calls (SCEP); Type: OTHER; Interventions: Behavioral: educational instruction and phone follow-up | Intervention Type: BEHAVIORAL; Name: educational instruction and phone follow-up; Assigned to Arm(s): 3 Standard Care + Educational + Phone Calls (SCEP) | Intervention Type: BEHAVIORAL; Name: educational instruction in clinic; Assigned to Arm(s): 2 Standard Care + Educational (SCE)
B: Intervention Type: BEHAVIORAL; Name: Quick start oral contraceptive initiation; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Text messaging reminders | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Text messaging reminders; Assigned to Arm(s): 1
D: Arm Label: Reproductive Life Planning (RLP); Type: EXPERIMENTAL; Interventions: Behavioral: Reproductive Life Planning (RLP), Behavioral: Contraception information | Arm Label: Reproductive Life Planning Plus (RLP+); Type: EXPERIMENTAL; Interventions: Behavioral: Reproductive Life Planning (RLP), Behavioral: Contraceptive Action Planning, Behavioral: Contraception information | Arm Label: Information-only control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Contraception information | Intervention Type: BEHAVIORAL; Name: Reproductive Life Planning (RLP); Assigned to Arm(s): Reproductive Life Planning (RLP), Reproductive Life Planning Plus (RLP+) | Intervention Type: BEHAVIORAL; Name: Contraceptive Action Planning; Assigned to Arm(s): Reproductive Life Planning Plus (RLP+) | Intervention Type: BEHAVIORAL; Name: Contraception information; Assigned to Arm(s): Information-only control, Reproductive Life Planning (RLP), Reproductive Life Planning Plus (RLP+)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Adherence With Oral Contraceptives Using Daily Text Messaging Reminders
Brief Summary: The purpose of this study is to determine whether there is increased oral contraceptive pill (OCP) adherence in women receiving daily text messaging reminders to take their OCP, compared to women who do not receive reminders. The investigators hypothesize that women who receive daily text messaging reminders to take their OCP will have increased pill adherence compared to women who do not receive reminders.

The investigators also hope to determine whether there is a difference in OCP adherence as measured by electronic monitoring device and wireless real-time data collection versus traditional patient pill diaries. The investigators hypothesize that electronic monitoring device and wireless real-time data collection will demonstrate lower adherence compared to traditional patient pill diaries.


Options:
A: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Text Messages; Type: EXPERIMENTAL; Interventions: Other: Daily Text Messages | Intervention Type: OTHER; Name: Daily Text Messages; Assigned to Arm(s): Text Messages
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Cell Phone Intervention | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Cell Phone Intervention; Assigned to Arm(s): 1
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Text messaging reminders | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Text messaging reminders; Assigned to Arm(s): 1
D: Arm Label: Mobile phone-based intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone-based intervention | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mobile phone-based intervention; Assigned to Arm(s): Mobile phone-based intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Adherence With Oral Contraceptives Using Daily Text Messaging Reminders
Brief Summary: The purpose of this study is to determine whether there is increased oral contraceptive pill (OCP) adherence in women receiving daily text messaging reminders to take their OCP, compared to women who do not receive reminders. The investigators hypothesize that women who receive daily text messaging reminders to take their OCP will have increased pill adherence compared to women who do not receive reminders.

The investigators also hope to determine whether there is a difference in OCP adherence as measured by electronic monitoring device and wireless real-time data collection versus traditional patient pill diaries. The investigators hypothesize that electronic monitoring device and wireless real-time data collection will demonstrate lower adherence compared to traditional patient pill diaries.


Options:
A: Arm Label: Reciprocal Diabetes Peer Support program; Type: EXPERIMENTAL; Interventions: Behavioral: Reciprocal Diabetes Peer Support Program, Behavioral: group outpatient counseling visits | Arm Label: Nurse Case Management; Type: OTHER; Interventions: Behavioral: Nurse Case management | Intervention Type: BEHAVIORAL; Name: Reciprocal Diabetes Peer Support Program; Assigned to Arm(s): Reciprocal Diabetes Peer Support program | Intervention Type: BEHAVIORAL; Name: Nurse Case management; Assigned to Arm(s): Nurse Case Management | Intervention Type: BEHAVIORAL; Name: group outpatient counseling visits; Assigned to Arm(s): Reciprocal Diabetes Peer Support program
B: Arm Label: Adherence counseling; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Adherence counseling | Arm Label: Alarm device; Type: ACTIVE_COMPARATOR; Interventions: Device: Alarm device | Arm Label: Counseling and alarm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Adherence counseling, Device: Alarm device | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Adherence counseling; Assigned to Arm(s): Adherence counseling, Counseling and alarm | Intervention Type: DEVICE; Name: Alarm device; Assigned to Arm(s): Alarm device, Counseling and alarm
C: Arm Label: Arm 1: Collaborative Care Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative Care Interventions | Arm Label: Arm 2: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Collaborative Care Interventions; Assigned to Arm(s): Arm 1: Collaborative Care Intervention
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Text messaging reminders | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Text messaging reminders; Assigned to Arm(s): 1

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of Flaxseed Supplement on Cardio-metabolic Risk Factors in Patients With Metabolic Syndrome
Brief Summary: The purpose of this study is to determine whether daily supplement of 30 grams flaxseed is effective in the treatment of metabolic syndrome (MetS).


Options:
A: Arm Label: Consumption of 42 g of salted peanuts; Type: EXPERIMENTAL; Interventions: Other: Consumption of 42 grams of peanuts daily | Arm Label: Consumption of 42 g of unsalted peanuts; Type: EXPERIMENTAL; Interventions: Other: Consumption of 42 grams of peanuts daily | Arm Label: Consumption of 42 g of spicy peanuts; Type: EXPERIMENTAL; Interventions: Other: Consumption of 42 grams of peanuts daily | Arm Label: Consumption of 42 g of honey peanuts; Type: EXPERIMENTAL; Interventions: Other: Consumption of 42 grams of peanuts daily | Arm Label: Consumption of 42 g of 3 diff. varieties; Type: EXPERIMENTAL; Interventions: Other: Consumption of 42 grams of peanuts daily | Arm Label: Consumption of 42 g of var. of types; Type: EXPERIMENTAL; Interventions: Other: Consumption of 42 grams of peanuts daily | Intervention Type: OTHER; Name: Consumption of 42 grams of peanuts daily; Assigned to Arm(s): Consumption of 42 g of 3 diff. varieties, Consumption of 42 g of honey peanuts, Consumption of 42 g of salted peanuts, Consumption of 42 g of spicy peanuts, Consumption of 42 g of unsalted peanuts, Consumption of 42 g of var. of types
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Dietary Supplement: flaxseed, Behavioral: Health lifestyle counseling | Arm Label: B; Type: SHAM_COMPARATOR; Interventions: Behavioral: Health lifestyle counseling | Intervention Type: DIETARY_SUPPLEMENT; Name: flaxseed; Assigned to Arm(s): A | Intervention Type: BEHAVIORAL; Name: Health lifestyle counseling; Assigned to Arm(s): A, B
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Almond enriched diet | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low fat caloric diet | Intervention Type: BEHAVIORAL; Name: Almond enriched diet; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Low fat caloric diet; Assigned to Arm(s): 2
D: Arm Label: Brazil Nuts; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Brazil Nut | Intervention Type: DIETARY_SUPPLEMENT; Name: Brazil Nut; Assigned to Arm(s): Brazil Nuts

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase IV Study of the Use of Sequential DFP-DFO Versus DFP in Thalassemia Major Patients
Brief Summary: Changes in chelation treatment and transfusion practices, during the past two decades, have dramatically improved the prognosis of thalassemia major patients.Deferiprone (DFP) has been compared with deferoxamine (DFO), using different schedules of treatment, in the majority of the 13 clinical trials published between 1990 and 2008.No statistically significant difference was shown between these two interventions during, at most, 18 months of treatment.Three randomised trials that compared sequential DFP-DFO treatment versus DFO alone reported controversial results but this could be due to small sample sizes and short treatment duration. In fact, no trial with treatment duration longer than 18 months15, which reported on mortality, adverse events, serum ferritin concentrations, as well as costs has so far been published.

This long-term sequential DFP-DFO treatment versus DFP alone treatment trial was conducted to assess the impacts of these chelation treatments on serum ferritin concentrations, mortality, adverse events, and costs in thalassemia major patients.


Options:
A: Arm Label: ICL670; Type: EXPERIMENTAL; Interventions: Drug: ICL670 | Arm Label: Deferoxamine; Type: ACTIVE_COMPARATOR; Interventions: Drug: deferoxamine | Intervention Type: DRUG; Name: ICL670; Assigned to Arm(s): ICL670 | Intervention Type: DRUG; Name: deferoxamine; Assigned to Arm(s): Deferoxamine
B: Arm Label: Deferiprone; Type: EXPERIMENTAL; Interventions: Drug: Deferiprone | Arm Label: Deferasirox; Type: ACTIVE_COMPARATOR; Interventions: Drug: Deferasirox | Intervention Type: DRUG; Name: Deferiprone; Assigned to Arm(s): Deferiprone | Intervention Type: DRUG; Name: Deferasirox; Assigned to Arm(s): Deferasirox
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Deferiprone (DFP) and Deferoxamine (DFO) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Deferiprone (DFP) | Intervention Type: DRUG; Name: Deferiprone (DFP) and Deferoxamine (DFO); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Deferiprone (DFP); Assigned to Arm(s): 2
D: Arm Label: ICL670 (Deferasirox); Type: EXPERIMENTAL; Interventions: Drug: Deferasirox | Intervention Type: DRUG; Name: Deferasirox; Assigned to Arm(s): ICL670 (Deferasirox)

Answer: C